Home » Newsletters » BioWorld Science

BioWorld Science

June 23, 2000

View Archived Issues

Meningococcal C conjugate vaccine shown to be safe and immunogenic in infants

Thrombopoietin preparation shows no clinical benefit in myeloid leukemia

Researchers repair gene mutation responsible for muscular dystrophy in dogs

New research strengthens link between COX-2 and angiogenesis/tumor growth

Celltech Group highlights recent advances for key products at annual general meeting

Tumor-associated antigen-derived immunogenic polypeptides useful for cancer immunotherapy

Antiplatelet compounds in early development at Welfide superior to cilostazol in activity, safety

Recent patent describes Galderma's latest series of vitamin D analogues

New compounds synthesized at Teijin favorably affect lipid profiles

Senju's new aldose reductase inhibitors have potential for diabetic complications

Daiichi commences development of new anticancer compound

Procyon's Q3 marked by progress on all fronts

Potent and safe analgesics derived from tramadol patented by Vita-Invest

Agents for use in BPH in development at Merck & Co.

Boehringer Ingelheim claims thrombin inhibitor series

Mechanism of apoptosis induction elucidated for NIK-333

BIIL-284: preclinical profile of a new, orally active LTB4 antagonist

Cardio- and neuroprotective effects of NCX-4016 highlighted at recent conference

Alexion highlights Q3 progress of five phase II trials with 5G1.1

Inhibitors of multiple leukotrienes in development for asthma at Czech research institute

PD-170292: a nonpeptide compound with full agonist activity at the high-affinity CCK1 site

Advanced Magnetics receives FDA action letter for Combidex contrast agent

NO-indomethacin derivative compares favorably with indomethacin regarding GI effects

HemispheRx Biopharma files marketing application in E.U. for Ampligen

Merck Frosst launches Varivax II for protection against chickenpox

Palatin Technologies to begin development of PT-141 for treatment of erectile dysfunction